Cancer has long been called a silent killer, not because it lacks signs, but because those signs often arrive too late. For decades, oncology was dominated by a reactive model: patients presented with symptoms, received a diagnosis, and began treatment at an advanced stage when outcomes were already compromised. Today, that narrative is being rewritten. Early-stage cancer diagnosis can increase five-year survival rates dramatically. For breast cancer, early detection pushes survival rates above 99%; for lung cancer, catching the disease at Stage I versus Stage IV means the difference between a 60% survival rate and less than 6%. The numbers make one thing undeniable: ...
